Platanoside Prevents Ferroptosis in Acute Lung Injury through Keap1 Degradation-Mediated Activation of the Nrf2/GPX4 Axis

Study Background and Research Question

Acute lung injury (ALI) is a critical condition marked by severe inflammation, loss of redox homeostasis, and breakdown of the alveolar–capillary barrier, leading to high mortality rates of 30–40% in intensive care settings (paper). Existing treatments, such as mechanical ventilation and anti-inflammatory agents, frequently yield suboptimal outcomes due to limited specificity and single-pathway targeting. A major pathological driver in ALI is ferroptosis—an iron-dependent, lipid peroxidation-driven form of regulated cell death. The Nrf2/GPX4 axis is central to cellular antioxidant defense and ferroptosis regulation, but whether upregulating this pathway by specifically targeting its upstream suppressor Keap1 offers tangible therapeutic benefit in ALI remained to be rigorously tested (paper).

Key Innovation from the Reference Study

This study identifies platanoside (PLA), a naturally occurring flavonoid glycoside, as a novel modulator of the Nrf2/GPX4 axis. PLA induces autophagy-dependent degradation of Keap1, the principal negative regulator of Nrf2. By facilitating Keap1 removal, PLA enhances Nrf2 nuclear translocation and subsequent GPX4 upregulation, thereby inhibiting ferroptosis in an ALI model. This mechanistic insight establishes PLA as a promising candidate for pathologies where redox imbalance and ferroptotic cell death are critical components (paper).

Methods and Experimental Design Insights

The research combined in vivo and mechanistic cell biology approaches:

• Animal Model: Lipopolysaccharide (LPS)-induced ALI in mice served as the primary in vivo model to recapitulate the inflammatory and oxidative environment of human ALI.
• PLA Treatment: Mice received PLA administration prior to and/or after LPS challenge to assess both prophylactic and therapeutic potential.
• Histopathological Analysis: Lung tissue sections were stained using hematoxylin and eosin to evaluate morphological changes and inflammatory infiltration, enabling quantitative assessment of tissue damage and cellular structure (paper).
• Molecular and Biochemical Assays: Levels of Keap1, Nrf2, and GPX4 were assessed by immunoblotting and immunofluorescence. Ferroptosis was evaluated via quantification of lipid peroxidation markers (4-hydroxynonenal, malondialdehyde) and mitochondrial ultrastructural integrity.
• Mechanistic Dissection: Co-immunoprecipitation and protein–protein interaction assays revealed PLA’s direct engagement with Keap1 and its facilitation of p62/SQSTM1-mediated autophagic degradation.

Protocol Parameters

• assay | H&E tissue staining | applicability: paraffin-embedded and frozen lung sections | rationale: enables visualization of cellular and tissue morphology changes in ALI and assessment of inflammatory infiltration | source_type: paper
• assay | PLA dosage 10–40 mg/kg | applicability: mouse model of LPS-induced ALI | rationale: dose-response assessment for protective effect | source_type: paper
• assay | LPS challenge (5 mg/kg, intratracheal) | applicability: induction of ALI in mice | rationale: standard protocol for modeling acute inflammatory lung injury | source_type: paper
• assay | immunoblotting for Keap1/Nrf2/GPX4 | applicability: lung tissue and cell lysates | rationale: quantification of pathway protein expression | source_type: paper
• assay | lipid peroxidation marker quantification | applicability: assessment of ferroptosis in lung tissue | rationale: direct measurement of ferroptosis activity | source_type: paper
• assay | immunofluorescence and electron microscopy | applicability: subcellular localization and morphological analysis | rationale: visualization of Nrf2 translocation and mitochondrial integrity | source_type: paper
• assay | H&E kit use with 3–5 min hematoxylin, 1–2 min eosin | applicability: optimized for murine lung sections | rationale: workflow_recommendation | source_type: workflow_recommendation

Core Findings and Why They Matter

PLA administration in LPS-induced ALI mice produced several notable effects:

• Significantly reduced Keap1 protein levels in lung tissue, indicating effective induction of Keap1 degradation (paper).
• Promoted nuclear translocation of Nrf2 and upregulated GPX4 expression, signifying enhanced antioxidant defense.
• Decreased lipid peroxidation products (4-hydroxynonenal, malondialdehyde), showing robust inhibition of ferroptosis.
• Ameliorated histopathological lung damage, including diminished alveolar wall thickening, reduced inflammatory cell infiltration, and preserved tissue architecture as visualized by H&E staining (paper).
• Electron microscopy confirmed PLA’s ability to maintain mitochondrial structure, further supporting mitigation of cell death.

Mechanistic studies revealed that PLA increases p62/SQSTM1–Keap1 complex formation, directing Keap1 toward autophagic degradation and establishing a feed-forward regulatory loop that amplifies Nrf2 activity. This provides an integrated solution for simultaneously managing inflammation, oxidative stress, and ferroptosis—key challenges in ALI management.

Comparison with Existing Internal Articles

The histopathological assessment in this study leveraged robust H&E staining to reveal changes in tissue morphology and cellular architecture during ALI progression and therapeutic intervention. This aligns with perspectives in internal resources—such as the article "Redefining Cellular Insight: Harnessing H&E Staining for Translational Research" (internal article)—which underscore the value of optimized nuclear and cytoplasmic staining for dissecting cell death pathways, including ferroptosis, and supporting biomarker translation. Similarly, "Hematoxylin and Eosin (H&E) Staining Kit: Unveiling Molecular Mechanisms" (internal article) discusses how high-resolution morphology visualization is indispensable for correlating molecular changes with tissue pathology. This study demonstrates the practical convergence of pathway-focused research and advanced histological analysis, validating the translational utility of standardized staining workflows.

Limitations and Transferability

Despite its strong mechanistic and in vivo evidence, the study’s findings are currently limited to murine models of ALI induced by LPS, which may not fully capture the heterogeneity of human lung injury (paper). The specificity of PLA for the Keap1–Nrf2–GPX4 axis and its pleiotropic effects in other cell types or organs require further investigation. In addition, long-term biosafety, optimal dosing, and pharmacokinetics of PLA have yet to be established. Transfer to clinical settings will necessitate rigorous validation in diverse preclinical models and eventual human trials.

Research Support Resources

To facilitate similar mechanistic and histopathological investigations, researchers can employ robust tools for tissue morphology visualization and cellular structure assessment. The Hematoxylin and Eosin Staining Kit (SKU K1142) from APExBIO is suitable for both paraffin-embedded and frozen tissue sections and provides ready-to-use reagents for reproducible nuclear and cytoplasmic staining. This kit supports precise evaluation of histopathological changes in preclinical models of ALI and other inflammatory conditions, promoting reliable integration of morphological and molecular data (workflow_recommendation).